3-(4-甲基-1-哌嗪)丙-1-醇，CAS 登记号 5317-33-9，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 3-(4-甲基-1-哌嗪)丙-1-醇 的 CAS 号：5317-33-9，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
3-(4-methyl-1-piperazine)propan-1-ol · CAS 5317-33-9 · C8H18N2O. UNII XB7DBM2RWE.
| CAS Registry Number | 5317-33-9 |
|---|---|
| PubChem CID | 79208 |
| Molecular formula | C8H18N2O |
| IUPAC name | 3-(4-methylpiperazin-1-yl)propan-1-ol |
| UNII (FDA) | XB7DBM2RWE |
| Molecular Weight | 158.24 |
|---|---|
| XLogP3 | -0.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 158.141913202 |
| Monoisotopic Mass | 158.141913202 |
| Topological Polar Surface Area | 26.7 |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (75%), H312 (75%), H315 (75%), H319 (75%), H332 (75%), H335 (75%) |
|---|
H302 (75%): Harmful if swallowed [Warning Acute toxicity, oral]
H312 (75%): Harmful in contact with skin [Warning Acute toxicity, dermal]
3-(4-Methyl-1-piperazine)propan-1-ol; EINECS 226-177-6; DTXSID80201235; NSC 351986; RefChem:493272; DTXCID80123726; 226-177-6; 5317-33-9; 1-(3-Hydroxypropyl)-4-methylpiperazine; 3-(4-methylpiperazin-1-yl)propan-1-ol; 4-Methyl-1-piperazinepropanol; MFCD00009781; 1-Piperazinepropanol, 4-methyl-; 3-(n-methylpiperazine)-propanol; NSC-351986; 1-piperazinepropanol, 4-methyl-, dihydrochloride
CAS 5317-33-9; molecular formula C8H18N2O; molecular weight — g/mol.
3-(4-Methyl-1-piperazine)propan-1-ol, EINECS 226-177-6, DTXSID80201235, NSC 351986, RefChem:493272, DTXCID80123726.
Hazard statements reported: H302, H312, H315, H319, H332.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.